Skip to main content
AAPL $252.32 +1.24% MSFT $396.27 -0.93% GOOGL $303.24 -1.35% AMZN $207.85 +0.47% NVDA $181.44 +1.43% TSLA $393.69 -0.83% META $617.15 -1.32% JPM $286.08 -1.32% V $307.40 +0.00% WMT $125.79 +0.95% AAPL $252.32 +1.24% MSFT $396.27 -0.93% GOOGL $303.24 -1.35% AMZN $207.85 +0.47% NVDA $181.44 +1.43% TSLA $393.69 -0.83% META $617.15 -1.32% JPM $286.08 -1.32% V $307.40 +0.00% WMT $125.79 +0.95%

NASDAQ: CORT

Corcept Therapeutics Incorporated

Healthcare • Biotechnology • www.corcept.com

$33.87 $-0.52 (-1.61%)

As of Mar 13, 3:54 PM UTC

CORT Latest News

HC Wainwright & Co. Maintains Buy on Corcept Therapeutics, Lowers Price Target to $60
2 weeks ago | Benzinga
Corcept Therapeutics (NASDAQ:CORT) Stock Falls After Q4 Earnings Miss Estimates
2 weeks ago | ChartMill
Corcept Therapeutics Incorporated (CORT) Q4 2025 Earnings Call Transcript
2 weeks ago | SeekingAlpha
Corcept Therapeutics Sees FY2026 Sales $900.000M-$1.000B vs $975.114M Est
2 weeks ago | Benzinga
Corcept Therapeutics Q4 EPS $0.20 Misses $0.27 Estimate, Sales $202.125M Miss $254.936M Estimate
2 weeks ago | Benzinga
Corcept Therapeutics Earnings Preview
3 weeks ago | Benzinga
7 Analysts Assess Corcept Therapeutics: What You Need To Know
3 weeks ago | Benzinga
HC Wainwright & Co. Maintains Buy on Corcept Therapeutics, Lowers Price Target to $67
3 weeks ago | Benzinga
Corcept Therapeutics: The Bad News Is Priced In; The Ovarian Cancer Upside Is Not
3 weeks ago | SeekingAlpha
Corcept Therapeutics Stock Plunges As Court Clears Teva Generic
3 weeks ago | Benzinga
Corcept Therapeutics shares are trading lower after a court of appeals for the federal circuit affirmed a no-infringement decision that favored Teva Pharmaceuticals.
3 weeks ago | Benzinga
Federal Circuit Affirmed A No-Infringement Win For Teva Pharmaceutical Industries Vs Corcept Therapeutics Over Korlym (Mifepristone) Dosing With Strong CYP3A Inhibitors
3 weeks ago | Benzinga
Corcept Therapeutics Inc (NASDAQ:CORT) Presents a Compelling GARP Investment Case
4 weeks ago | ChartMill
Options Exercise: Hazel Hunt At Corcept Therapeutics Realizes $5.53M
4 weeks ago | Benzinga
Is Corcept Therapeutics Incorporated (CORT) The Most Promising Growth Stock According to Analysts?
2 months ago | Yahoo
One Rare Disease Biotech Posts 97% Margins but the Faster Growing Rival Just Turned Its First Profit
2 months ago | Yahoo
Corcept Insider Transaction Explained After Shares Tumble 50% in One Day
2 months ago | Yahoo
Top Growth Companies With Significant Insider Ownership
2 months ago | Yahoo
Top Growth Companies With Insider Ownership In January 2026
2 months ago | Yahoo
Price Targets Lowered on Corcept Therapeutics (CORT) After FDA Letter
2 months ago | Yahoo
Corcept Therapeutics Incorporated's (NASDAQ:CORT) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
2 months ago | Yahoo
January 2026's Top Growth Companies With Insider Confidence
2 months ago | Yahoo
January 2026 Top Growth Stocks With Insider Influence
2 months ago | Yahoo
3 Growth Companies With Insider Ownership Up To 27%
2 months ago | Yahoo
Why Corcept (CORT) Stock Is Trading Lower Today
2 months ago | Yahoo
Corcept (CORT) Surges 9.8%: Is This an Indication of Further Gains?
2 months ago | Yahoo
Corcept Therapeutics Incorporated $CORT Shares Sold by First Trust Advisors LP
3 months ago | defenseworld.net
Corcept Therapeutics Incorporated $CORT Shares Sold by First Trust Advisors LP
3 months ago | defenseworld.net
Corcept Therapeutics Incorporated $CORT Shares Sold by First Trust Advisors LP
3 months ago | defenseworld.net
Corcept Therapeutics Incorporated $CORT Shares Sold by First Trust Advisors LP
3 months ago | defenseworld.net
Corcept Therapeutics Incorporated $CORT Shares Sold by First Trust Advisors LP
3 months ago | defenseworld.net
Corcept Therapeutics Incorporated $CORT Shares Sold by First Trust Advisors LP
3 months ago | defenseworld.net
Cerity Partners LLC Buys 131,799 Shares of Corcept Therapeutics Incorporated $CORT
3 months ago | defenseworld.net
Cerity Partners LLC Buys 131,799 Shares of Corcept Therapeutics Incorporated $CORT
3 months ago | defenseworld.net
Cerity Partners LLC Buys 131,799 Shares of Corcept Therapeutics Incorporated $CORT
3 months ago | defenseworld.net
Cerity Partners LLC Buys 131,799 Shares of Corcept Therapeutics Incorporated $CORT
3 months ago | defenseworld.net
Cerity Partners LLC Buys 131,799 Shares of Corcept Therapeutics Incorporated $CORT
3 months ago | defenseworld.net
Cerity Partners LLC Buys 131,799 Shares of Corcept Therapeutics Incorporated $CORT
3 months ago | defenseworld.net
Corcept (CORT) Up 9.2% Since Last Earnings Report: Can It Continue?
3 months ago | zacks.com
Corcept (CORT) Up 9.2% Since Last Earnings Report: Can It Continue?
3 months ago | zacks.com
Corcept (CORT) Up 9.2% Since Last Earnings Report: Can It Continue?
3 months ago | zacks.com
Corcept (CORT) Up 9.2% Since Last Earnings Report: Can It Continue?
3 months ago | zacks.com
Corcept (CORT) Up 9.2% Since Last Earnings Report: Can It Continue?
3 months ago | zacks.com
Corcept (CORT) Up 9.2% Since Last Earnings Report: Can It Continue?
3 months ago | zacks.com
Will Korlym Continue to Drive Corcept's Top Line in 2026?
3 months ago | zacks.com
Will Korlym Continue to Drive Corcept's Top Line in 2026?
3 months ago | zacks.com
Will Korlym Continue to Drive Corcept's Top Line in 2026?
3 months ago | zacks.com
Will Korlym Continue to Drive Corcept's Top Line in 2026?
3 months ago | zacks.com
Will Korlym Continue to Drive Corcept's Top Line in 2026?
3 months ago | zacks.com
Will Korlym Continue to Drive Corcept's Top Line in 2026?
3 months ago | zacks.com

FEATURED BY